Posted by Michael Wonder on 29 Apr 2020
EMA publishes agenda for 28-30 April CHMP meeting
29 April 2020 - The EMA has published a draft agenda for this week's CHMP meeting.
The CHMP is due to issue initial opinions for the following technologies:
- Cabazitaxel
- Glasdegib acetate
- Mometasone furoate with indacaterol maleate with glycopyrronium bromide
- Fingolimod hydrochloride
- Insulin aspart
- Paliperidone
- Luspatercept
